As of June 21, 2025, Prothena Corporation PLC (PRTA) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Prothena Corporation PLC's Forward P/E to Peers
To better understand Prothena Corporation PLC's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Prothena Corporation PLC (PRTA) | - |
| Horizon Therapeutics PLC (HZNP) | 25.39 |
| Alkermes Plc (ALKS) | 16.42 |
Compared to its competitors, Prothena Corporation PLC's Forward P/E is difficult to compare due to insufficient data.